Nandrolone 17-Propionate

Modify Date: 2024-01-02 17:08:15

Nandrolone 17-Propionate Structure
Nandrolone 17-Propionate structure
Common Name Nandrolone 17-Propionate
CAS Number 7207-92-3 Molecular Weight 330.461
Density 1.1±0.1 g/cm3 Boiling Point 453.6±45.0 °C at 760 mmHg
Molecular Formula C21H30O3 Melting Point N/A
MSDS N/A Flash Point 197.1±28.8 °C

 Use of Nandrolone 17-Propionate


Nandrolone propionate is an anabolic steroid with a relatively long duration of action primarily consisting of androgenic and nitrogen-retentive properties[1].

 Names

Name Nandrolone 17-propionate
Synonym More Synonyms

 Nandrolone 17-Propionate Biological Activity

Description Nandrolone propionate is an anabolic steroid with a relatively long duration of action primarily consisting of androgenic and nitrogen-retentive properties[1].
Related Catalog
References

[1]. Lydén E, et al. Effects of nandrolone propionate on experimental tumor growth and cancer cachexia. Metabolism. 1995 Apr;44(4):445-51.

 Chemical & Physical Properties

Density 1.1±0.1 g/cm3
Boiling Point 453.6±45.0 °C at 760 mmHg
Molecular Formula C21H30O3
Molecular Weight 330.461
Flash Point 197.1±28.8 °C
Exact Mass 330.219482
PSA 43.37000
LogP 4.42
Vapour Pressure 0.0±1.1 mmHg at 25°C
Index of Refraction 1.540

 MSDS


Section1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name: Nandrolone 17-propionate
CAS-No.: 7207-92-3
Relevant identified uses of the substance or mixture and uses advised against
Identified uses: Laboratory chemicals, Manufacture of substances



Section2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Carcinogenicity (Category 2)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Limited evidence of a carcinogenic effect. Danger of serious damage to health by prolonged exposure.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal wordWarning
Hazard statement(s)
H351Suspected of causing cancer.
Precautionary statement(s)
P281Use personal protective equipment as required.
Supplemental Hazardnone
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R40Limited evidence of a carcinogenic effect.
R48Danger of serious damage to health by prolonged exposure.
S-phrase(s)
S22Do not breathe dust.
S24/25Avoid contact with skin and eyes.
Other hazards - none

Section3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula: C21H30O3
Molecular Weight: 330,46 g/mol
ComponentConcentration
17-ß-Hydroxyestr-4-en-3-one 17-propionate
CAS-No.7207-92-3-
EC-No.230-587-0

Section4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
Some steroids show carcinogenic and teratogenic activity.
Indication of any immediate medical attention and special treatment needed
no data available

Section5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

Section6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

Section7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
no data available

Section8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Impervious clothing., The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle
respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering
controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use
respirators and components tested and approved under appropriate government standards such
as NIOSH (US) or CEN (EU).

Section9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) AppearanceForm: solid
b) Odourno data available
c) Odour Thresholdno data available
d) pHno data available
e) Melting point/freezingno data available
point
f) Initial boiling point and no data available
boiling range
g) Flash pointno data available
h) Evaporation rateno data available
i) Flammability (solid, gas) no data available
j) Upper/lowerno data available
flammability or
explosive limits
k) Vapour pressureno data available
l) Vapour densityno data available
m) Relative densityno data available
n) Water solubilityno data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignitionno data available
temperature
q) Decompositionno data available
temperature
r) Viscosityno data available
s) Explosive propertiesno data available
t) Oxidizing propertiesno data available
Other safety information
no data available

Section10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
no data available
Hazardous decomposition products
Other decomposition products - no data available

Section11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
Limited evidence of carcinogenicity in animal studies
IARC:No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
InhalationMay be harmful if inhaled. May cause respiratory tract irritation.
IngestionMay be harmful if swallowed.
SkinMay be harmful if absorbed through skin. May cause skin irritation.
EyesMay cause eye irritation.
Signs and Symptoms of Exposure
Some steroids show carcinogenic and teratogenic activity.
Additional Information
RTECS: Not available

Section12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

Section14. TRANSPORT INFORMATION
UN number
ADR/RID: 2811IMDG: 2811IATA: 2811
UN proper shipping name
ADR/RID: TOXIC SOLID, ORGANIC, N.O.S. (17-ß-Hydroxyestr-4-en-3-one 17-propionate)
IMDG: TOXIC SOLID, ORGANIC, N.O.S. (17-ß-Hydroxyestr-4-en-3-one 17-propionate)
IATA:Toxic solid, organic, n.o.s. (17-ß-Hydroxyestr-4-en-3-one 17-propionate)
Transport hazard class(es)
ADR/RID: 6.1IMDG: 6.1IATA: 6.1
Packaging group
ADR/RID: IIIMDG: IIIATA: II
Environmental hazards
ADR/RID: noIMDG Marine Pollutant: noIATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Hazard Codes Xn: Harmful;
Risk Phrases R40;R48
Safety Phrases S22-S24/25
RIDADR UN 2811
Packaging Group III
Hazard Class 6.1(b)

 Synthetic Route

~%

Nandrolone 17-Propionate Structure

Nandrolone 17-P...

CAS#:7207-92-3

Literature: US2798879 , ;

 Precursor & DownStream

Precursor  2

DownStream  0

 Synonyms

17β-Hydroxyestr-4-en-3-one propionate
19-Nortestosterone Propionate
19-Nor-D4-androsten-17b-ol-3-one Propionate
19-NORTESTOSTERONE 17-PROPIONATE
Nortesto
EINECS 230-587-0
Estr-4-en-3-one, 17-(1-oxopropoxy)-, (17β)-
(17β)-3-Oxoestr-4-en-17-yl propionate
N AND ROLON 17-PROPIONATE
19-nor-Testosteron-propionat
(17β)-3-oxoestr-4-en-17-yl propanoate
NANDROLONE PROPIONATE
Norybol-19
Nandrolone 17B-propionate
17b-Hydroxyestr-4-en-3-one Propionate
MFCD00198408
Nandrolone propionat
17b-(1-Oxopropoxy)estr-4-en-3-one
Top Suppliers:I want be here



Get all suppliers and price by the below link:

Nandrolone 17-Propionate suppliers

Nandrolone 17-Propionate price